웨어러블 심방세동 감지 기기 시장 : 시장 기회, 성장 촉진요인, 산업 동향 분석, 예측(2025-2034년)

The Global Wearable Atrial Fibrillation Detection Devices Market was valued at USD 596.2 million in 2024 and is estimated to grow at a CAGR of 17.4% to reach USD 3 billion by 2034. The Global Wearable Atrial Fibrillation Detection Devices Market was valued at USD 596.2 million in 2024 and is estimated to grow at a CAGR of 17.4% to reach USD 3 billion by 2034. The market growth is primarily fueled by the escalating incidence of atrial fibrillation, broader awareness about cardiovascular health, and increasing demand for remote monitoring technologies. As populations continue to age worldwide, the risk of atrial fibrillation rises, further driving the need for continuous heart rhythm monitoring. Wearable devices-such as patches, smartwatches, and compact monitors-are becoming popular as they combine ease of use with real-time health tracking. These innovations are designed to monitor heart rhythm through electrocardiogram (ECG) signals or blood flow patterns, ensuring efficient detection of irregular heartbeats.

Improvements in miniaturization and sensor precision have enabled these devices to deliver accurate insights without disrupting daily routines. Additionally, the integration of machine learning and artificial intelligence into wearables enhances their analytical capabilities, allowing the identification of subtle rhythm irregularities that may go unnoticed using traditional methods. With a rising focus on preventive care, these advancements are reinforcing market demand and adoption at a global scale.

The smartwatches segment generated USD 370.5 million in 2024, due to their multifunctionality and convenience. These devices integrate advanced ECG features alongside traditional capabilities such as fitness tracking and communication tools, which make them highly appealing to a broad consumer base. The ability to perform continuous cardiac monitoring, deliver health alerts, and fit seamlessly into daily life has made smartwatches a preferred option for atrial fibrillation detection. Enhanced sensors and algorithms embedded in these wearables further elevate detection accuracy and reliability, driving consumer and clinical trust.

The photoplethysmography (PPG) segment is forecast to reach USD 2 billion by 2034. PPG-based wearables offer a non-invasive, affordable, and efficient solution for continuous heart rate monitoring. These devices use light-based technology to detect changes in blood volume, enabling the identification of potential arrhythmias like atrial fibrillation. Because PPG sensors are less costly and easier to integrate into consumer electronics, they are widely adopted in fitness trackers and lifestyle smartwatches. Their ease of use and ability to generate real-time alerts further contribute to rising demand and market expansion.

U.S. Wearable Atrial Fibrillation Detection Devices Market generated USD 265.3 million in 2024 due to widespread use of digital health technologies, higher healthcare expenditure, and growing emphasis on preventive care. As the American population ages, more individuals are turning to wearable devices for proactive cardiovascular monitoring. The presence of a strong digital health ecosystem, including partnerships between tech firms and healthcare providers, has further accelerated product adoption and innovation in the region.

Major companies shaping the Wearable Atrial Fibrillation Detection Devices Market include CardiacSense, ALIVECOR, Garmin, Google, Circular, Samsung, Withings, Apple, QARDIO, PHILIPS, iRHYTHM, ATsens, and Huawei. Companies in the wearable atrial fibrillation detection space are actively leveraging several strategies to strengthen their foothold. Product innovation remains central, with firms investing in enhancing sensor sensitivity and improving real-time ECG and PPG capabilities.

Advanced AI and machine learning models are being developed to boost detection accuracy and provide predictive analytics. Strategic partnerships with healthcare institutions help integrate wearables into remote patient monitoring systems. Companies are also focusing on miniaturization and improving user comfort to drive long-term device use. Regulatory approvals and clinical validation remain top priorities to enhance trust and market credibility.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/Country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis
• 2.2 Key market trends
  • 2.2.1 Regional
  • 2.2.2 Product type
  • 2.2.3 Technology
  • 2.2.4 Distribution channel
• 2.3 CXO perspectives: Strategic imperatives
  • 2.3.1 Key decision points for industry executives
  • 2.3.2 Critical success factors for market players
• 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing incidence of atrial fibrillation
    • 3.2.1.2 Technological advancements
    • 3.2.1.3 Surge in demand for telemedicine and remote monitoring
    • 3.2.1.4 Increasing awareness about atrial fibrillation
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Complex regulatory landscape
    • 3.2.2.2 Issues related to accuracy and reliability
  • 3.2.3 Opportunities
    • 3.2.3.1 Integration with healthcare systems
    • 3.2.3.2 Emergence of AI and machine learning
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
• 3.5 Technology and innovation landscape
  • 3.5.1 Current technological trends
  • 3.5.2 Emerging technologies
• 3.6 Pricing analysis
• 3.7 Future market trends
• 3.8 Gap analysis
• 3.9 Porter's analysis
• 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
  • 4.2.1 Global
  • 4.2.2 North America
  • 4.2.3 Europe
  • 4.2.4 Asia Pacific
  • 4.2.5 Latin America
  • 4.2.6 MEA
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers and acquisitions
  • 4.6.2 Partnerships and collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Smartwatches
• 5.3 Patch monitors
• 5.4 Portable ECG monitors

Chapter 6 Market Estimates and Forecast, By Technology, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Photoplethysmography (PPG) based
• 6.3 Electrocardiogram (ECG) based

Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 E-commerce
• 7.3 Brick and mortar

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 ALIVECOR
• 9.2 Apple
• 9.3 ATsens
• 9.4 CardiacSense
• 9.5 Circular
• 9.6 Garmin
• 9.7 Google
• 9.8 Huawei
• 9.9 iRHYTHM
• 9.10 PHILIPS
• 9.11 QARDIO
• 9.12 Samsung
• 9.13 Withings